Leiden University Medical Center — Sponsor Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

5 Recruiting

7 Completed trials

6 Countries active

29 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 4 Phase II: 4 Phase III/IV: 1 Phase IV: 3

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Tinnitus 1 Colon cancer stage II 1 Injection site pain 1 Otitis media 1 Vestibular disorder 1 Endolymphatic hydrops 1 Vertigo 1 Dizziness 1 Oral contraception 1 Tympanic membrane perforation 1 Colon cancer stage III 1 Meniere's disease 1

Top IMPs

FENTANYL CITRATE 2 NALOXONE HYDROCHLORIDE 2 NALOXONE HYDROCHLORIDE DIHYDRATE 2 ACETYLCYSTEINE 1 CHIMERIC MONOCLONAL ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN CONJUGATED TO FLUOROCHROME BM-104 1 CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE 1 CLINDAMYCIN 1 DEXAMETHASONE 1 DOXYCYCLINE 1 DURVALUMAB 1 ESKETAMINE 1 GENTAMICIN 1

All trials

12 total

PREMI trial Recruiting

2023-503220-76-01 Phase IV 1 country
Treatment of Menière's disease with intratympanic methylprednisolone (PREDMEN trial) Recruiting

2023-503340-13-00 Phase III 1 country DEXAMETHASONE; GENTAMICIN; METHYLPREDNISOLONE; METOCLOPRAMIDE; SODIUM CHLORIDE; …
The RiCOTTA study: Rifampicin Combination Therapy versus Targeted Antibiotic Monotherapy for Infected Joint Prostheses Caused by Staphylococ… Recruiting

2022-501620-26-00 Phase IV 1 country CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN;…
Pneumococcal vaccine response in lymph nodes Recruiting

2022-501519-15-00 Phase II 1 country PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIU…
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Phase III 6 countries DURVALUMAB
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Phase III 1 country
WOMEN&More: Efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive Ended

2022-502694-41-00 Phase III 1 country MIFEPRISTONE
Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN Ended

2023-504615-33-00 Phase II 1 country CHIMERIC MONOCLONAL ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN CONJUGATED TO FLUO…
Comparison of multiple doses of intramuscular versus intranasal naloxone for reversal of opioid toxicity Ended

2023-505338-93-00 Phase II 1 country FENTANYL CITRATE; NALOXONE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE
Evaluation of sensory testing to measure the effects of tetrodotoxin Ended

2022-500318-24-00 Phase II 1 country TETRODOTOXIN
Hypoxic ventilatory response (HVR): Effect of Esketamine Ended

2023-504229-37-00 Phase IV 1 country ESKETAMINE; NALOXONE HYDROCHLORIDE; REMIFENTANIL
Effect of a pain killer on breathing and another drug that stimulates breathing Ended

2023-503912-34-00 Phase III/IV 1 country ACETYLCYSTEINE; FENTANYL CITRATE; NALOXONE HYDROCHLORIDE DIHYDRATE

Showing 1–12 of 12 trials

← All sponsors A–Z